1. Academic Validation
  2. USP7 protects TFEB from proteasome-mediated degradation

USP7 protects TFEB from proteasome-mediated degradation

  • Cell Rep. 2024 Oct 15;43(11):114872. doi: 10.1016/j.celrep.2024.114872.
Swati Keshri 1 Mariella Vicinanza 1 Michael Takla 1 David C Rubinsztein 2
Affiliations

Affiliations

  • 1 Cambridge Institute for Medical Research, University of Cambridge, CB2 0XY Cambridge, UK; UK Dementia Research Institute, Cambridge Biomedical Campus, Cambridge, UK.
  • 2 Cambridge Institute for Medical Research, University of Cambridge, CB2 0XY Cambridge, UK; UK Dementia Research Institute, Cambridge Biomedical Campus, Cambridge, UK. Electronic address: dcr1000@cam.ac.uk.
Abstract

The transcription factor EB (TFEB) is a master regulator of lysosomal biogenesis and Autophagy. We identify a distinct nuclear interactome of TFEB, with Ubiquitin-Specific Protease 7 (USP7) emerging as a key post-translational modulator of TFEB. Genetic depletion and inhibition of USP7 reveal its critical role in preserving TFEB stability within both nuclear and cytoplasmic compartments. Specifically, USP7 is identified as the Deubiquitinase responsible for removing the K48-linked polyubiquitination signal from TFEB at lysine residues K116, K264, and K274, thereby preventing its proteasomal degradation. Functional assays demonstrate the involvement of USP7 in preserving TFEB-mediated transcriptional responses to nutrient deprivation while also modulating Autophagy flux and lysosome biogenesis. As USP7 is a Deubiquitinase that protects TFEB from proteasomal degradation, these findings provide the foundation for therapeutic targeting of the USP7-TFEB axis in conditions characterized by TFEB dysregulation and metabolic abnormalities, particularly in certain cancers.

Keywords

CP: Cell biology; CP: Molecular biology; TFEB; USP7; autophagy; lysosomal biogenesis; post-translational modifications; proteasomal degradation; ubiquitination.

Figures
Products